Project Grant R43AG097164
Award Date 9/20/25
Completion Date 9/19/26
Dollars Obligated $354K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Sunnyvale, CA 94089, USA
Similar Awards
- This Project Grant award of $387,006 from the National Institute on Aging (NIA) under CFDA Program 93.866 - Aging Research supports research to understand how indoles derived from commensal gut bacteria can promote mobility and counteract sarcopenia (age-related muscle wasting) in aging animals. The research aims to determine the mechanisms by which indoles regulate muscle protein homeostasis, mitochondrial function, and other cellular pathways to maintain muscle mass and function during...
- This $644,864 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports preclinical studies by Ridgeline Therapeutics LLC, a Houston-based biotech company, to evaluate the efficacy of their lead compound RT-002 in preventing and reversing disuse-induced muscle atrophy in aging rat models. Specifically, the project aims to determine if RT-002 treatment can mitigate the loss of muscle mass and strength during muscle disuse, as well as improve the rate...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $1,339,717 to Ridgeline Therapeutics LLC to conduct preclinical validation of a novel small molecule drug to prevent muscle loss and enhance weight loss in older adults. The funding supports research and development of compounds that inhibit nicotinamide N-methyltransferase (NNMT), a validated target for addressing obesity, age-related muscle degeneration, and related metabolic conditions. Key...
- This $485,375 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund research at the University of Washington to investigate genomic alterations in skeletal muscle associated with aging. The key objectives are to: Explore if alternative splicing of mRNA results in quantitative differential isoform changes associated with aging, potentially leading to increased expression of non-functional proteins relevant for healthy muscle function. The researchers...
- The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $216,460 project grant to The Research Foundation For The State University Of New York, operating as Upstate Medical Center. The grant will support research to investigate the mechanism by which mitochondrial protein import stress can induce myokine signaling, and how this signaling may mediate fat loss and improve cardiac health during aging. The project aims to advance scientific...
- The National Institute on Aging (NIA) awarded a $333,125 Project Grant under the Aging Research (CFDA 93.866) federal grant program to George Washington University. The grant, which runs from September 17, 2024 to August 31, 2025, will fund the development and validation of artificial intelligence algorithms to predict body composition and physical function in older adults using low-cost 3D optical body scanning technology. The research aims to provide accessible and scalable methods to assess...
- The National Institute on Aging (CFDA 93.866 Aging Research) awarded a $506,000 Project Grant to the Scripps Research Institute to engineer a novel biomolecular condensate (BMC)-based tool with tunable physicochemical properties. The goal is to create an orthogonal selective autophagy receptor (SAR)-like BMC capable of supporting autophagosome biogenesis and selective cargo recruitment. This will enable detailed investigation of the biophysical regulatory mechanisms of BMCs in autophagy, which...
- The federal Project Grant award R56AG080294 in the amount of $440,000.00 was provided by the National Institute on Aging under their Aging Research program (CFDA 93.866). The grant supports research at the Beckman Research Institute of the City of Hope aimed at understanding the role of circadian clock regulation in the development of sarcopenic obesity, which is the loss of skeletal muscle mass and function with obesity in older adults. The research will employ transcriptomics and...
- This federal Project Grant award of $291,913 was provided by the National Institute on Aging (CFDA 93.866 - Aging Research) to Virscio, Inc., a for-profit research company located in Connecticut. The award is focused on developing epigenetic and senescent biomarkers using non-human primate tissues to advance the understanding of biological aging processes and potential anti-aging strategies. The project aims to create minimally invasive biomarker tools, such as blood and skin-based assays,...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,126,515 to Trustees of Indiana University in Indianapolis, IN to conduct research aimed at understanding how the L-BAIBA/FGF23 axis, an interaction between muscle and bone, can be targeted to enhance musculoskeletal health and resilience in aging populations. The research seeks to elucidate the mechanisms by which this muscle-bone signaling pathway becomes dysregulated with age, leading to...
The National Institute on Aging (NIA) awarded a $354,000 Project Grant under the Aging Research program (CFDA 93.866) to Panorama Research Incorporated, a for-profit biotech company in Sunnyvale, CA. The grant supports research to develop a novel therapy for sarcopenia, characterized by age-related loss of skeletal muscle mass, quality, and strength. The proposed therapy is based on the adipokine Isthmin 1 (ISM1), which has been shown to promote protein synthesis and suppress degradation pathways in muscle cells. The research aims to generate longer-lived versions of ISM1 and evaluate their efficacy in a rodent model of sarcopenic obesity. The grant period runs from September 20, 2025 to September 19, 2026.
Generated 10/21/25, 6:49 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $354.0k | 9/18/25 |